RadioImmunotherapy for adenoid cystic carcinoma: a single-institution series of combined treatment with cetuximab

BACKGROUND: Local control in adjuvant/definitive RT of adenoid cystic carcinoma (ACC) is largely dose-dependent. However, some clinical situations do not allow application of tumouricidal doses (i.e. re-irradiation) hence radiation sensitization by exploitation of high endothelial growth factor rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Alexandra D, Krauss, Jürgen, Weichert, Wilko, Debus, Jürgen, Münter, Marc W
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987937/
https://www.ncbi.nlm.nih.gov/pubmed/21047402
http://dx.doi.org/10.1186/1748-717X-5-102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987937/
https://www.ncbi.nlm.nih.gov/pubmed/21047402
http://dx.doi.org/10.1186/1748-717X-5-102

Ejemplares similares